Activity Release Date: 12/21/2020
Activity Expiration Date: 12/21/2022
2.25 hour activity
InjectAbility® Institute’s activity, “Earning a Patient’s Trust Through A Thorough and Educational Consultation”, aims to provide action items that practitioners can implement to enhance the new patient’s experience at their clinic. Several of the practical action items being discussed are: spending extended time educating the patient, sitting while consulting, using staff to enhance the experience, and using images to elicit anticipation for positive outcomes. Once this step-by-step experience has been assimilated, the new patient is more likely to trust the provider’s prescribed dose and more likely to desire optimal, pan-facial outcomes.
Healthcare providers will be given the confidence to take back the consultation as the medical practitioner. Instead of acquiescing as patients ask for certain dosing, or specific products in certain areas, providers should confidently continue the messaging that these are medical procedures, and that they are medical clinicians implementing these procedures.
Simple steps and key phrasing to unfolding budgetary discussions will be modeled for you in a mock consultation. Follow the ‘patient’s’ journey from walking into the clinic, through the consultation where she was requesting neuromodulator, and finally completing the patient’s visit by hearing her state the instant boost of confidence she received after viewing her four-syringe pan-facial results.
This activity has been designed to meet the educational needs of physicians, physician assistants, nurse practitioners, registered nurses and dentists involved in the care of patients undergoing non-surgical aesthetic procedures.
Upon completion of the educational activity, participants should be able to:
- Integrate subliminal messaging throughout their office, as well as in consult design.
- Describe new ways to inspire the patient to move from “consultation” to “implementation” and finally to “validation” of procedures received, using the four-part consultation process.
- Recognize value in time spent with patients educating them throughout the entire new patient/consultative process.
- Replicate the new patient/consultative process outlined in the lecture effectively into practice.
- Integrate the pre-cryptic screening and official screening of patients for BDD, enabling realistic outcomes and expectations.
CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and InjectAbility® Institute. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 2.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit being awarded: 2.25 ANCC contact hours
AAPA Credit Designation Statement – Enduring
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.25 AAPA Category 1 CME credits. Approval is valid until December 21, 2022. PAs should only claim credit commensurate with the extent of their participation.
AKH Inc Advancing Knowledge in Healthcare is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
AKH Inc Advancing Knowledge in Healthcare designates this activity for 2.25 continuing education credits.
Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and InjectAbility® Institute. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 2.25 contact hour(s) (which includes 0 hour(s) of pharmacology).
This activity is supported by an educational grant from Allergan, Accuvein, and FotoFinder.
Criteria for Success
In order to receive credit, participants should watch the entire video. Once you have watched the video, you will continue to the online quiz and evaluation. A passing score of 70% on the quiz is required to receive credit. A certificate will be available in your transcripts upon successful completion of the quiz and evaluation. If you have questions about this CE activity, please contact AKH Inc. at [email protected]. There is no fee for this activity.
ABOUT OUR FACULTY
Leslie Fletcher – RN, MSN, AGNP-BC
Board-certified Nurse Practitioner, Leslie Fletcher, NP-BC is a highly respected aesthetic nurse injector who since 2001, has worked with world-renowned, celebrity dermatologists and plastic surgeons. In November 2019 she was named the “Best Aesthetic Nurse in the US” and her clinic was voted “Best Medical Spa” in the world by her peers in the largest global aesthetic awards, My Face, My Body. The successful medical clinic she founded in 2010 located in Los Angeles, CA has been ranked in the top 0.05% of the nation for use of neuromodulators and dermal filler use and in 2019 was named one of Inc. 5000 fastest growing of all companies in the US.
She is sought out as an international speaker at aesthetic conferences, and faculty injection trainer for some of the most prestigious aesthetic training companies and pharmaceutical companies in the world where she has trained over 6,000 practitioners globally and is recognized as a key opinion leader. She has authored over 20 medical aesthetic articles published in peer-reviewed journals such as the Journal of Cosmetic Dermatology (JCD) as well as the Journal of Aesthetic Nursing (JAN) where she serves on the editorial board.
She also imparts her knowledge through her work as a faculty injection trainer for several companies, including Allergan® and as a consultant on multiple advisory boards for Allergan, Revance® therapeutics, ZO® Skin Health, and Endo Aesthetics.
In 2020 she was given the esteemed honor by Allergan/AbbVie of serving as one of four practitioners nationwide who consult as an expert in the area of adverse events advising practitioners all over the country through complications with their patients. These experiences combined with her astute artistic skills and ability to cultivate and energize her trainees makes Leslie a valuable industry resource for aesthetic medical practitioners worldwide.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CE expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review. AKH planners and reviewers have no relevant financial relationships to disclose
Leslie Fletcher has disclosed the following relevant financial relationships:
Consultant – Allergan Aesthetics, Revance Therapeutics, Endo International, ZO Skin Health, Evolus
Speakers Bureau – Allergan Aesthetics
Stock – Revance Therapeutics, Endo International
AKH Staff And Planners Disclosures
Dorothy Caputo, MA, BSN, RN, Director of Accreditation, Lead Nurse Planner: has nothing to disclose.
Bernadette Marie Makar, MSN, NP-C, APRN-C, Nurse Planner/Reviewer: has nothing to disclose.
Francis Caputo, MD, FACS: Consultant – Bolton, Endologix
Margaret Varnell Clark, MS, RN, RRT, NPS: has nothing to disclose.
Dorothy Duffy, BS Pharmacy: has nothing to disclose.
Agatha Dziedziech-Eckert, DDS: has nothing to disclose.
Lawrence J. Michalski: has nothing to disclose.
Karen Lazovic : has nothing to disclose.
Patricia Brignoni, AKH Sr. Project Manager: has nothing to disclose.
Steve Eckert, AKH President & CEO, Planner: has nothing to disclose.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.
**Please note, parts of this webinar were filmed before and parts were filmed after COVID-19. Please make any adjustments to patient care according to your state regulations.
Copyright 2020 AKH Inc. No part of this publication may be produced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical photocopying, recording, or otherwise, without the prior permission of the publisher.